We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Untethered Proteins Could Help Diagnose MKD

By LabMedica International staff writers
Posted on 30 May 2017
Mevalonate Kinase Deficiency (MKD), also known as HIDS (hyper IgD syndrome), is a rare genetic condition that affects approximately 200 individuals worldwide. More...
It is a spectrum of disease, with complications that range from mild to severe. MKD is one of more than 8,000 known rare and genetic conditions, which, although individually uncommon, collectively affect up to 10% of the population.

Individuals with MKD experience recurrent and frequent attacks of high fever, which are associated with pain in the joints, muscles and abdomen, along with skin rash. Attacks of fever can last for several days and occur periodically throughout life. In its severest form, also known as mevalonic aciduria, MKD can be life-threatening, and can involve neurological symptoms and impaired growth.

Scientists at the Garvan Institute of Medical Research developed a highly sensitive in vitro prenylation assay that enables the detection of unprenylated small GTPase proteins in cell lysates. Human peripheral blood monocytes (PBMCs) were isolated from buffy coat preparations of fresh blood samples and cell pellets were snap frozen before analysis. The scientists performed Western blots and in vitro prenylated (i.e., biotinylated) proteins were detected on polyvinylidene difluoride blots using streptavidin-680RD. Blots were also analyzed for unprenylated Rap1A using goat anti-Rap1A.

The team showed that, within the cells, several proteins from the same family (known as Rab proteins) had no isoprenoid 'tail', a molecule that is usually added to these proteins in the final stages of preparing them for their work in the cell. An isoprenoid tail is thought to act as a molecular 'tether' for the protein it is attached to. The isoprenoid tails on Rab proteins keep them in a particular area of the cell close to the cell membrane. Without their tethers, the Rab proteins, and other related proteins, are 'on the loose' in the cells of children with MKD, and are free to move into other parts of the cell. It is thought that this could set off the disease process in MKD, triggering inflammation. Untethered Rab proteins are found only in people in MKD. They are not present in the cells of people with other rare diseases that have similar clinical symptoms (the periodic fever syndromes) or in the parents of children with MKD.

Michael J. Rogers, PhD, a professor and chief investigator, said, “It has been thought for some time that individuals with MKD might have untethered Rab proteins, because we know that a gene called mevalonate kinase (MVK), which is altered in MKD, is important in making the isoprenoid tails that are fitted onto these proteins. Until now, though, no one has been able to show that these untethered proteins do in fact build up in the cells of kids with MKD. To see these proteins directly, and to show that they are lacking their ‘tails’ is an important advance in our understanding of this devastating disease.” The study was published on May 10, 2017, in the Journal of Allergy and Clinical Immunology.


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.